ES2101824T3 - N-acil-n-heterociclil-onaftalenil-alquil-aminoacidos como antagonistas de angiotensina ii. - Google Patents
N-acil-n-heterociclil-onaftalenil-alquil-aminoacidos como antagonistas de angiotensina ii.Info
- Publication number
- ES2101824T3 ES2101824T3 ES92810603T ES92810603T ES2101824T3 ES 2101824 T3 ES2101824 T3 ES 2101824T3 ES 92810603 T ES92810603 T ES 92810603T ES 92810603 T ES92810603 T ES 92810603T ES 2101824 T3 ES2101824 T3 ES 2101824T3
- Authority
- ES
- Spain
- Prior art keywords
- instead
- alkyl
- variables
- carbonyl
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000005862 Angiotensin II Human genes 0.000 title 1
- 101800000733 Angiotensin-2 Proteins 0.000 title 1
- CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 title 1
- 229950006323 angiotensin ii Drugs 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- -1 1H-TETRAZOLE-5-YL Chemical group 0.000 abstract 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 229910018828 PO3H2 Inorganic materials 0.000 abstract 1
- 229910006069 SO3H Inorganic materials 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical class O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- CFHIDWOYWUOIHU-UHFFFAOYSA-N oxomethyl Chemical compound O=[CH] CFHIDWOYWUOIHU-UHFFFAOYSA-N 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- KHUXNRRPPZOJPT-UHFFFAOYSA-N phenoxy radical Chemical class O=C1C=C[CH]C=C1 KHUXNRRPPZOJPT-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Indole Compounds (AREA)
- Peptides Or Proteins (AREA)
- Pyrrole Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
LA INVENCION SE REFIERE A AMINOACIDOS N-ACILO-NHETEROCICLILOALQUILO DE LA FORMULA EN LA QUE R1 SIGNIFICA ALQUILO C1-C7, EL CUAL ESTA INSUSTITUIDO O ESTA SUSTITUIDO POR HALOGENO O HIDROXIDO, O SIGNIFICA ALQUENILO C2-C7, CICLOALQUILOC3-C7, CICLOALQUILOXILO C3-C7, ALCOXILOC1-C7 O CICLOALQUILOC3-C7-ALCOXILOC1-C7; R2 ES 1H-TETRAZOL-5-YL, CARBOXILO, ALCOXILO-CARBONILO-C1-C7, SO3H, PO2H2, PO3H2 O HALOGENO-C1-C7-ALCANOSULFONILAMINO; R3 SIGNIFICA 1H-TETRAZOL-5-YL, HIDROXIMETILO, ALCOXI-METILO-C1-C7, FORMILO, CARBOXILO, ALCOXI-CARBONILO-C1-C7, C1-C7 ALCOXILOCARBONILO-C1-C7, C1-C7ALCOXILO-C1-C7-ALCOXILO-CARBONILO, FENIL-C1-C4ALCOXILO-CARBONILO O CARBAMOYLO, CUYO GRUPO AMINO ESTA INSUSTITUIDO O ESTA DISUSTITUIDO POR ALQUILO C1-C7, ALQUENILO-C1-C7 O FENILO-C1-C7-ALQUILO MONO O INDEPENDIENTE ENTRE SI O ESTA DISUSTITUIDO POR AQUILENO C2-C7 O C2-C4-ALQUILENOXILO-C2-C4; ALK METILEL, ES ETILEL O ETILIDEL HET, SIGNIFICA (I) EN LA QUE Y1 ESTA EN LUGAR DE O, S O N(R) Y R SIGNIFICA ALQUILOC1-C7; O SIGNIFICA (II)EN LA QUE UNA DE LAS VARIABLES Y2 E Y3 ESTA EN LUGAR DE C(R'') Y LA OTRA EN LUGAR DE N, O LAS DOS VARIABLES EN LUGAR DE C(R''); Y R'' SIGNIFICA HIDROGENO, HALOGENO, ALQUILO-C1-C7, ALCOXILO-C1-C7, ALQUENILOXILO-C2-C7, FELOXILO, BENCILOXILO, TRIFLUOROMETILO O S(O)M-R, EN DONDE M, ES 0, 1 O 2; Y R ES HIDROGENO O ALQUILOU EL INDICE M ESTA EN LUGAR DE 0, 1 O 2; UNA DE LAS VARIABLES X2 Y X4 ESTA EN LUGAR DE ALQUILOS-C1-C4 Y LAS OTRAS VARIABLES X2 Y X4 ESTAN EN LUGAR DE UN ENLACE; O LAS DOS VARIABLES X2 Y X4 ESTAN CADA VEZ EN LUGAR DE UN ENLACE; X3 SIGNIFICA C3-C7-CICLOALQUILIDOS O EL ELEMENTO DE ESTRUCTURA C(XA)(XB) IDROGENO O ALQUILO-C1-C7 Y XB ES ALQUILO C1-C7; Y LOS ANILLOS A, B, C Y D, HASTA LOS SUSTITUYENTES INDICADOS EN LA FORMULA, ASI COMO LOS SUSTITUYENTES AROMATICOS, ESTAN INSUSTITUIDOS INDEPENDIENTES ENTRE SI O SUSTITUIDOS UNA O VARIAS VECES POR SUSTITUYENTES ESCOGIDOS DEL GRUPO COMPUESTO DE HALOGENO, ALQUILO-C1-C7, ALCOXILO-C1-C7, ALQUENILOXILO-C2-C7, FENOXILO, BENCILOXILO, TRIFLUOROMETILO Y S(O)M-R, EN DONDE M, ES 0, 1 O 2; Y R ES HIDROGENO O ALQUILO-C1-C7; Y SUS SALES; METODO PARA LA FABRICACION, PREPARADOS FARMACEUTICOS QUE CONTIENEN UNA COMBINACION DE LA FORMULA I O UNA SAL DE ELLA DE EMPLEO FARMACEUTICO, ASI COMO EL EMPLEO.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH240591 | 1991-08-15 | ||
| CH37592 | 1992-02-07 | ||
| CH114192 | 1992-04-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2101824T3 true ES2101824T3 (es) | 1997-07-16 |
Family
ID=27172057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES92810603T Expired - Lifetime ES2101824T3 (es) | 1991-08-15 | 1992-08-06 | N-acil-n-heterociclil-onaftalenil-alquil-aminoacidos como antagonistas de angiotensina ii. |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US5955487A (es) |
| EP (1) | EP0528762B1 (es) |
| JP (1) | JPH05230022A (es) |
| KR (1) | KR930004295A (es) |
| AT (1) | ATE152718T1 (es) |
| AU (1) | AU659469B2 (es) |
| CA (1) | CA2076057A1 (es) |
| DE (1) | DE59208448D1 (es) |
| DK (1) | DK0528762T3 (es) |
| ES (1) | ES2101824T3 (es) |
| FI (1) | FI923612A7 (es) |
| GR (1) | GR3023708T3 (es) |
| HU (1) | HUT62880A (es) |
| IL (1) | IL102802A0 (es) |
| MX (1) | MX9204703A (es) |
| NO (1) | NO923182L (es) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2683819B1 (fr) * | 1991-10-28 | 1994-02-11 | Synthelabo | Derives de quinoleine, leur procede de preparation et leur application en therapeutique. |
| GB9208116D0 (en) | 1992-04-13 | 1992-05-27 | Ici Plc | Therapeutic agents |
| ES2135472T3 (es) * | 1992-04-13 | 1999-11-01 | Zeneca Ltd | Antagonistas de angiotensina ii contra trastornos asociados con la velocidad de conduccion neuronal deteriorada, especialmente la neuropatia diabetica. |
| US5478832A (en) * | 1992-05-08 | 1995-12-26 | The Green Cross Corporation | Quinoline compounds |
| GB9218449D0 (en) | 1992-08-29 | 1992-10-14 | Boots Co Plc | Therapeutic agents |
| FR2710914B1 (fr) * | 1993-10-04 | 1995-11-24 | Synthelabo | Dérivés de 2-[2-(tétrazol-5-yl)phényl]-1,2-dihydroquinoléine, leur préparation et leur utilisation comme intermédiaires de synthèse. |
| JPH09202774A (ja) | 1996-01-25 | 1997-08-05 | Green Cross Corp:The | ２−アリールキノリン類およびその製造方法 |
| US5919792A (en) * | 1996-10-30 | 1999-07-06 | Merck & Co., Inc. | Integrin antagonists |
| JP3892963B2 (ja) * | 1998-03-17 | 2007-03-14 | 住友化学株式会社 | Ｌ−バリンベンジルエステルｐ−トルエンスルホン酸塩の製造方法 |
| SE9903028D0 (sv) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
| TW200505442A (en) * | 2003-05-19 | 2005-02-16 | Genomics Inst Of The Novartis Res Foundation | Immunosuppressant compounds and compositions |
| MY150088A (en) * | 2003-05-19 | 2013-11-29 | Irm Llc | Immunosuppressant compounds and compositions |
| BRPI0412694A (pt) * | 2003-07-15 | 2006-10-03 | Smithkline Beecham Corp | compostos |
| US7868037B2 (en) | 2004-07-14 | 2011-01-11 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| US7772271B2 (en) | 2004-07-14 | 2010-08-10 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| JP2008507518A (ja) | 2004-07-22 | 2008-03-13 | ピーティーシー セラピューティクス，インコーポレーテッド | Ｃ型肝炎を治療するためのチエノピリジン |
| CN103601792B (zh) | 2007-06-04 | 2016-06-29 | 协同医药品公司 | 有效用于胃肠功能紊乱、炎症、癌症和其他疾病治疗的鸟苷酸环化酶激动剂 |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| AU2009256157B2 (en) | 2008-06-04 | 2014-12-18 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
| CA2775328A1 (en) * | 2009-09-23 | 2011-03-31 | Medivation Technologies, Inc. | Pyrido[4,3-b]indoles and methods of use |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| WO2014151206A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| US9486494B2 (en) | 2013-03-15 | 2016-11-08 | Synergy Pharmaceuticals, Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| EP4424697A3 (en) | 2013-06-05 | 2024-12-25 | Bausch Health Ireland Limited | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2417763A1 (de) * | 1974-04-11 | 1975-10-30 | Bayer Ag | Carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| ATE113281T1 (de) * | 1989-08-02 | 1994-11-15 | Takeda Chemical Industries Ltd | Pyrazol-derivate, verfahren zu deren herstellung und anwendung. |
| GB8924392D0 (en) * | 1989-10-30 | 1989-12-20 | Bayer Ag | Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides |
| GB8924755D0 (en) * | 1989-11-02 | 1989-12-20 | Bayer Ag | Iso-and heterocyclic phenylsulphonylamides |
| PT95899A (pt) * | 1989-11-17 | 1991-09-13 | Glaxo Group Ltd | Processo para a preparacao de derivados indole |
| GB8927277D0 (en) * | 1989-12-01 | 1990-01-31 | Glaxo Group Ltd | Chemical compounds |
| CA2032259A1 (en) * | 1989-12-18 | 1991-06-19 | Wayne J. Thompson | Hiv protease inhibitors useful for the treatment of aids |
| DE59107440D1 (de) * | 1990-02-19 | 1996-04-04 | Ciba Geigy Ag | Acylverbindungen |
| AU657498B2 (en) * | 1990-12-14 | 1995-03-16 | Novartis Ag | Biphenylyl compounds |
| FR2689124A1 (fr) * | 1992-03-27 | 1993-10-01 | Adir | Nouvelles naphtylalkylamines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
-
1992
- 1992-08-06 EP EP92810603A patent/EP0528762B1/de not_active Expired - Lifetime
- 1992-08-06 ES ES92810603T patent/ES2101824T3/es not_active Expired - Lifetime
- 1992-08-06 DK DK92810603.8T patent/DK0528762T3/da not_active Application Discontinuation
- 1992-08-06 DE DE59208448T patent/DE59208448D1/de not_active Expired - Fee Related
- 1992-08-06 AT AT92810603T patent/ATE152718T1/de not_active IP Right Cessation
- 1992-08-12 AU AU20983/92A patent/AU659469B2/en not_active Ceased
- 1992-08-12 FI FI923612A patent/FI923612A7/fi not_active Application Discontinuation
- 1992-08-13 US US07/929,616 patent/US5955487A/en not_active Expired - Fee Related
- 1992-08-13 CA CA002076057A patent/CA2076057A1/en not_active Abandoned
- 1992-08-13 IL IL102802A patent/IL102802A0/xx unknown
- 1992-08-13 KR KR1019920014556A patent/KR930004295A/ko not_active Withdrawn
- 1992-08-14 NO NO92923182A patent/NO923182L/no unknown
- 1992-08-14 HU HU9202654A patent/HUT62880A/hu unknown
- 1992-08-14 MX MX9204703A patent/MX9204703A/es unknown
- 1992-08-17 JP JP4217716A patent/JPH05230022A/ja active Pending
-
1993
- 1993-07-27 US US08/097,740 patent/US5506240A/en not_active Expired - Fee Related
-
1995
- 1995-06-07 US US08/472,102 patent/US5620998A/en not_active Expired - Fee Related
-
1997
- 1997-06-09 GR GR970401349T patent/GR3023708T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2098392A (en) | 1993-02-25 |
| DK0528762T3 (da) | 1997-08-25 |
| HUT62880A (en) | 1993-06-28 |
| FI923612A0 (fi) | 1992-08-12 |
| MX9204703A (es) | 1993-12-01 |
| DE59208448D1 (de) | 1997-06-12 |
| AU659469B2 (en) | 1995-05-18 |
| US5506240A (en) | 1996-04-09 |
| JPH05230022A (ja) | 1993-09-07 |
| EP0528762B1 (de) | 1997-05-07 |
| US5620998A (en) | 1997-04-15 |
| HU9202654D0 (en) | 1992-10-28 |
| NO923182D0 (no) | 1992-08-14 |
| EP0528762A1 (de) | 1993-02-24 |
| CA2076057A1 (en) | 1993-02-16 |
| US5955487A (en) | 1999-09-21 |
| FI923612A7 (fi) | 1993-02-16 |
| NO923182L (no) | 1993-02-16 |
| KR930004295A (ko) | 1993-03-22 |
| IL102802A0 (en) | 1993-01-31 |
| ATE152718T1 (de) | 1997-05-15 |
| GR3023708T3 (en) | 1997-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2101824T3 (es) | N-acil-n-heterociclil-onaftalenil-alquil-aminoacidos como antagonistas de angiotensina ii. | |
| MXPA06002880A (es) | Derivados 1,1,1-trifluoro-4-fenil-4-metil-2-(1h-pirrolo `2,3-cipiridin-2-ilmetil) pentan-2-ol y compuestos relacionados como ligandos glucorticoides para el tratamiento de enfermedades inflamatorias y diabetes. | |
| CO5080799A1 (es) | Nuevos derivados sustituidos del pirazol | |
| MX2023014274A (es) | Compuestos indol sustituidos y metodos de uso de los mismos. | |
| AR045761A1 (es) | Derivados de 2-piridona como inhibidores de elastasa de neutrofilos | |
| GT200500183A (es) | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
| PE20180462A1 (es) | Moduladores cot y metodos de uso de los mismos | |
| AR072787A1 (es) | Compuestos y composiciones como inhibidores de cinasa | |
| GT200300269A (es) | Nuevos derivados fluoroglucosidos aromaticos, medicamentos que contienen estos compuestos y sus usos | |
| AR052232A1 (es) | Derivados de 5-heteroariltiazoles | |
| PA8442201A1 (es) | Derivados de 6-fenilpiridil-2-amina | |
| AR056875A1 (es) | Ligandos del receptor vaniloide y su aplicacion para la fabricacion de medicamentos | |
| ES2093645T3 (es) | Nueva clase de compuestos que tienen un espectro variable de actividades para respuestas de tipo capsaicina, composiciones y usos de los mismos. | |
| ES2076147T3 (es) | Nuevos derivados de amina ciclicos, medicamento que contiene estos compuestos y procedimiento para su preparacion. | |
| GT200600518A (es) | Derivados de pirimidina | |
| ECSP105253A (es) | Derivados de 5-feniltiazol y uso como inhibidores de pi3 cinasa | |
| PE20050822A1 (es) | Derivados de florfenicol con mejor solubilidad en agua | |
| GT200100254A (es) | Nuevas imidazotriazinonas sustituidas | |
| AR042733A1 (es) | Derivados de piridinas utilizados como inhibidores del mecanismo de intercambio na+/ca2+ | |
| HN2003000063A (es) | Derivados de nicotinamida y una sal de tiotropio en combinacion para el tratamiento de enfermedades. | |
| AR004158A1 (es) | Compuesto de ftalizin-pirido dionas; composición farmacéutica que lo contiene; y proceso para la preparación de dicho compuesto. | |
| AR053778A1 (es) | Compuestos de quinazolina para el tratamiento de desordenes mediados por la proteina quinasa | |
| AR061637A1 (es) | Composiciones y metodos de tratamiento de trastornos del snc | |
| ES2072263T3 (es) | Derivados de 4-aminopiridina. | |
| GT200300108A (es) | Derivados de benzoxazina y usos de los mismos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 528762 Country of ref document: ES |